{
    "root": "2f9c7d6f-7f0f-f9dd-e063-6294a90abf59",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Axumin",
    "value": "20250305",
    "ingredients": [
        {
            "name": "SODIUM CITRATE, UNSPECIFIED FORM",
            "code": "1Q73Q2JULR",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_53258"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32145"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        },
        {
            "name": "FLUCICLOVINE F-18",
            "code": "38R1Q0L1ZE",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_176400"
        }
    ],
    "indications": {
        "text": "axumin indicated positron emission tomography ( pet ) men suspected prostate cancer recurrence based elevated blood prostate antigen ( psa ) levels following prior treatment .",
        "doid_entities": [
            {
                "text": "prostate cancer (DOID:10283)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10283"
            },
            {
                "text": "cancer (DOID:162)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_162"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "appropriate radiation safety handling measures ( 2.1 ) . aseptically withdraw axumin container administer 370 mbq ( 10 mci ) bolus intravenous injection . ( 2.2 ) . initiate imaging 3 minutes 5 minutes . scanning start mid-thigh proceed base skull , total scan time approximately 20 minutes 30 minutes ( 2.4 ) . ( radiation absorbed ) effective dose associated 370 mbq ( 10 mci ) injected activity axumin approximately 8 msv ( 0.8 rem ) adult ( 2.6 ) .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": null,
    "adverseReactions": "none",
    "indications_original": "Axumin is indicated for positron emission tomography (PET) in men with suspected prostate cancer recurrence based on elevated blood prostate specific antigen (PSA) levels following prior treatment.",
    "contraindications_original": "Use appropriate radiation safety handling measures ( 2.1 ). Aseptically withdraw Axumin from its container and administer 370 MBq (10 mCi) as a bolus intravenous injection. ( 2.2 ). Initiate imaging 3 minutes to 5 minutes after administration. Scanning should start from mid-thigh and proceed to base of skull, with a total scan time of approximately 20 minutes to 30 minutes ( 2.4 ). The (radiation absorbed) effective dose associated with 370 MBq (10 mCi) of injected activity of Axumin is approximately 8\u00a0mSv (0.8 rem) in an adult ( 2.6 ).",
    "adverseReactions_original": "None",
    "drug": [
        {
            "name": "Axumin",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_53258"
        }
    ]
}